S. Bougaret, Apport des connaissances de la CMP dans les projets de développement pharmaceutique, mémoire pour la Certification de Maîtrise de Projet, AFITEP, 1998.

P. Droit, Bulletin trimestriel n°1, 1998.

V. Giard and C. Midler, Pilotages de projets et entreprises, ECOSIP, Editions ECONOMICA, 1993.

V. Giard, Gestion de projets, Editions ECONOMICA, 1991.

R. Herzog, Project management : practical aspects, p.7, 1994.

T. Kenedy, Pharmaceutical Project Management, 1998.

C. Kutzbach, Project planning from basic concepts to systems application, Drug and pharmaceutical sciences JT Kennedy, 1997.

&. Lehman and . Brothers, Expectations of R&D returns raised by access to enabling technologies", Building value from innovation, 1997.

J. F. Prost, Améliorer les transistions selon les phases clés des projets, Congrès IIR : quel management de projets pour développer de nouveaux médicaments, 1998.

B. Spilkerg, Multinational drug companies : issues in drug discovery and development, 1989.

S. Stringer, An Overview of How the Food and Drug Administration Regulates New Drug Development in the United States, Drug Information Journal, vol.47, issue.3, pp.745-751, 1996.
DOI : 10.1177/009286159603000318

R. Sikes, The pharmaceutical industry in the next millenium : capturing the scientific promise, CMR Annual 97 lecture, ED. Centre for Medecines Research International, 1997.

G. Wick, Using portfolio management as the missing link between project management and financial planning", Congrès IIR : developping and sustaining successful project management in the industry, 1997.